KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Treasury Shares (2017 - 2025)

Teladoc Health's Treasury Shares history spans 9 years, with the latest figure at $3.1 million for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 57.08% to $3.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.1 million, a 57.08% decrease, with the full-year FY2025 number at $3.1 million, down 57.08% from a year prior.
  • Treasury Shares hit $3.1 million in Q4 2025 for Teladoc Health, down from $7.2 million in the prior quarter.
  • Over the last five years, Treasury Shares for TDOC hit a ceiling of $11.4 million in Q1 2023 and a floor of $629672.0 in Q4 2022.
  • Historically, Treasury Shares has averaged $5.3 million across 5 years, with a median of $3.9 million in 2022.
  • Biggest five-year swings in Treasury Shares: skyrocketed 1375.41% in 2023 and later plummeted 79.21% in 2024.
  • Tracing TDOC's Treasury Shares over 5 years: stood at $2.1 million in 2021, then crashed by 70.26% to $629672.0 in 2022, then skyrocketed by 1375.41% to $9.3 million in 2023, then fell by 22.22% to $7.2 million in 2024, then tumbled by 57.08% to $3.1 million in 2025.
  • Business Quant data shows Treasury Shares for TDOC at $3.1 million in Q4 2025, $7.2 million in Q4 2024, and $8.1 million in Q3 2024.